PRESS RELEASE

publications

EVENTS

​MEDIA COVERAGE 

Scrip Informa Phama Intelligence - Osivax CEO Hopes Vaccines Maker Can Develop Universal Flu 'Silver Bullet'
Published on August 14, 2019

---

European Biotechnology -  €8M for universal flu vaccine​ ​
Published on July 11, 2019

---

RTBF - Une société biotech française séduite par Liège 
Published on July 11, 2019

---

BioWorld - Osivax advancing Universal flu vaccine with $9M  series A
Published on July 11, 2019

---

FierceBiotech - Osivax raises €8M for universal flu vaccine clinical trials 
Published on July 10, 2019

---

LABIOTECH.eu - French Startup's Universal Flu Vaccine Development Boosted by €8M  Series A
Published on July 10, 2019

---

EU-Startups - Lyon-based biotech startup Osivax raises €8 million in financing to develop novel, universal flu vaccines 
Published on July 10, 2019

---

FinSMEs - Osivax Raises €8M in Series A Funding 
Published on July 10, 2019

---

L'echo - Osivax s'installe à Liège pour y développer un vaccin universel contre la grippe 
​Published on July 10, 2019

---

Ccimag - Osivax lève 8 millions d’euros et planifie l’ouverture de bureaux à Liège 
Published on July 10, 2019

---

Siliconcanals - French biotech startup Osivax secures €8M to develop universal vaccine against influenza 
Published on July 10, 2019

---

LABIOTECH.eu - The Top 10 Biotechs You’ll Find in Lyon 
Published on July 10, 2019

---

LeProgres - Le vaccin contre la grippe d’Osivax pourrait générer plus d’un milliard par an 
Published on April 24, 2018

---

LABIOTECH.eu - This Newly Founded French Biotech is All About Vaccines
Published on June 23, 2017